The BROADEN Study: A Study of Volanesorsen (Formerly IONIS-APOCIIIRx) in Participants With Familial Partial Lipodystrophy
Stopped Study terminated early at a time point when sufficient data had been accumulated to inform a decision on further development of volanesoresen in participants with FPL.
Conditions
- Familial Partial Lipodystrophy
Interventions
- DRUG: volanesorsen
- DRUG: Placebo
Sponsor
Akcea Therapeutics
Collaborators